Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Chronic Pain associated with Painful Diabetic Neuropathy Market Expected to Rise by a CAGR of 15.18% by 2026, Estimates DelveInsight

This image opens in the lightbox

News provided by

DelveInsight Business Research, LLP

04 May, 2021, 17:00 GMT

Share this article

Share toX

Share this article

Share toX

Chronic Pain associated with Painful Diabetic Neuropathy market will surge due to an Increasing Rate of Diabetes and Growing Geriatric Population Globally

LAS VEGAS, May 4, 2021 /PRNewswire/ -- DelveInsight's Chronic Pain associated with Painful Diabetic Neuropathy Market and Competitive Landscape Report provides the current and forecast market of the Chronic Pain associated with Painful Diabetic Neuropathy devices and comprises considering market trends and key competitors.  

Key Highlights of Chronic Pain associated with Painful Diabetic Neuropathy Market report:

  • The highest contribution in the Chronic Pain associated with Painful Diabetic Neuropathy market size was the pharmacotherapy market with 95.2%, while the medical device market takes up only 4.8% in 2018, which is expected to increase by 2026 with the launch of new devices and increased awareness.
  • The highest contributor for Chronic Pain associated with Painful Diabetic Neuropathy market size is the United States with 60.19% and Japan with 12.95% among the 7MM.
  • The current treatments for neuropathic pain secondary to Painful Diabetic Neuropathy (PDN) are suboptimal and have limited effectiveness and intolerable side effects. The emerging medical devices are expected to show great results on the PDN population as they aim to address the chronic pain associated with PDN specifically.
  • In July 2020, the US Food and Drug Administration (FDA) approved the first use of a medicated patch made with capsaicin, Qutenza (8% capsaicin) by Grünenthal, and is approved for Painful Diabetic Neuropathy.
  • In December 2020, Nevro Corp. submitted a pre-market approval supplement to the US FDA to seek approval of its Senza® System for the Chronic Pain associated with Painful Diabetic Neuropathy treatment. The company expects to achieve approval and initiate US launch activities for the Senza System and HF10 therapy to treat Chronic Pain in Painful Diabetic Neuropathy patients in the second half of 2021.

Request for Sample Pages @ Chronic Pain associated with Painful Diabetic Neuropathy Market

Chronic Pain associated with Painful Diabetic Neuropathy Market

Diabetic Peripheral Neuropathy (PDN) is the most common complication of both type 1 and 2 diabetes and occurs in more than half of affected individuals in both hospital and clinic settings.

According to DelveInsight's estimates, the total prevalent cases of selected indications for Chronic Pain associated with Painful Diabetic Neuropathy were 7,670,318 cases in the 7MM in 2018 and are expected to get increased by 2030. The US accounted for the highest cases, with 3,782,136 cases in the same year.

Looking forward to the Medical device technology market for PDN, two technologies are available in the Chronic Pain associated with Painful Diabetic Neuropathy market approved over the years by the FDA and EMA. Transcutaneous electrical stimulation (TENS) is one low-cost option that patients can administer at home and used as a Diabetic Peripheral Neuropathy treatment.

Various pharmaceutical companies are developing Chronic Pain associated with Painful Diabetic Neuropathy therapies such as VM202 (Helixmith), NYX-2925 (Aptinyx), WST-057 (4% pirenzepine) (WinSanTor, Inc.), Ricolinostat (Regenacy Pharmaceuticals), NRD.E1 (Novaremed Ltd.), Cebranopadol (Grünenthal GmbH), GRC 17356 (Glenmark Pharmaceuticals), and others which are expected to enter the market by 2030 as effective therapies. Among all these therapies, gene therapy, VM202 is expected to hold the highest Chronic Pain associated with Painful Diabetic Neuropathy market share by 2026.

Key Competitors in Chronic Pain associated with Painful Diabetic Neuropathy Market:

  • Grünenthal
  • Daiichi Sankyo
  • Janssen Pharmaceuticals/Grunethal
  • Pfizer
  • Eli Lilly and Shionogi
  • Ono pharmaceuticals
  • Fremslife S.r.l.
  • Helixmith
  • Aptinyx
  • Regenacy Pharmaceuticals
  • Novaremed
  • Nevro Corp.
  • Erchonia Corporation
  • Regenesis Biomedical, Inc.
  • Abbott
  • ZyGood LLC

The market for Chronic Pain associated with Painful Diabetic Neuropathy devices is driven by increasing prevalence and incidence of diabetes due to sedentary and erratic lifestyles along with unhealthy diet habits, growing complexities related to diabetes that comprise nerve damage and blindness, the surging geriatric population globally, and technological advancements are factors responsible for the increase of the Chronic Pain associated with Painful Diabetic Neuropathy market size, considering at a high CAGR during the forecast period.

Know more about the key companies along with their drugs @ Chronic Pain associated with Painful Diabetic Neuropathy Competitive Landscape

Table of Contents

1

Chronic Pain associated with Painful Diabetic Neuropathy Background and Overview

2

Chronic Pain associated with Painful Diabetic Neuropathy Company Profiles

3

Chronic Pain associated with Painful Diabetic Neuropathy Competitive Analysis

4

Chronic Pain associated with Painful Diabetic Neuropathy Eligible Patient Pool Analysis (2018–2026)

4.1

Chronic Pain associated with Painful Diabetic Neuropathy in the U.S.

4.2

Chronic Pain associated with Painful Diabetic Neuropathy in EU-5

4.2.1

Chronic Pain associated with Painful Diabetic Neuropathy in Germany

4.2.2

 Chronic Pain associated with Painful Diabetic Neuropathy in France

4.2.3

Chronic Pain associated with Painful Diabetic Neuropathy in Spain

4.2.4

Chronic Pain associated with Painful Diabetic Neuropathy in Italy

4.2.5

Chronic Pain associated with Painful Diabetic Neuropathy in the UK

4.3

Chronic Pain associated with Painful Diabetic Neuropathy in Japan

5

Chronic Pain associated with Painful Diabetic Neuropathy Market Analysis in the 7MM (2018–2026)

5.1

Chronic Pain associated with Painful Diabetic Neuropathy Market in the US

5.2

Chronic Pain associated with Painful Diabetic Neuropathy Market in the EU-5

5.2.1

Chronic Pain associated with Painful Diabetic Neuropathy Market in Germany

5.2.2

Chronic Pain associated with Painful Diabetic Neuropathy Market in France

5.2.3

Chronic Pain associated with Painful Diabetic Neuropathy Market in Italy

5.2.4

Chronic Pain associated with Painful Diabetic Neuropathy Market in Spain

5.2.5

Chronic Pain associated with Painful Diabetic Neuropathy Market in the United Kingdom

5.3

Chronic Pain associated with Painful Diabetic Neuropathy Market Japan

6

Chronic Pain associated with Painful Diabetic Neuropathy Market Drivers and Market Barriers

7

Chronic Pain associated with Painful Diabetic Neuropathy SWOT Analysis

The report provides valuable insight for clients venturing into the Chronic Pain associated with Painful Diabetic Neuropathy devices and acts as the source of guidance for taking strategic business decisions in the field of Chronic Pain associated with Painful Diabetic Neuropathy devices by offering a thorough overview of pathophysiology, several diagnostic approaches, and treatment algorithm covering detailed chapters for marketed products and emerging therapies. Along with this, the report has a detailed review of the market containing historical and forecasted market size in 7MM by comprehension of the trends shaping and driving the global Chronic Pain associated with Painful Diabetic Neuropathy devices.

DelveInsight's analysts have prepared this report after a thorough secondary and primary research into the Chronic Pain associated with Painful Diabetic Neuropathy devices market. Analysis and estimations are done by taking into consideration the share of topmost companies and industry expert viewpoints of Chronic Pain associated with Painful Diabetic Neuropathy devices and also the prevalent patient population of 7MM countries.

Visit to know more about the report offerings @ Chronic Pain associated with Painful Diabetic Neuropathy Devices Market

 Related Reports

  • Diabetic Peripheral Neuropathy Market

DelveInsight's Diabetic Peripheral Neuropathy - Market Insights, Epidemiology and Market Forecast - 2030 report provides a depth understanding of historical and forecasted epidemiology.

  • Chemotherapy-induced Peripheral Neuropathy Market 

DelveInsight's Chemotherapy-induced Peripheral Neuropathy - Market Insights, Epidemiology and Market Forecast - 2030 report provides a detailed overview of the disease and a depth understanding of historical and forecasted epidemiology.

  • Peripheral Neuropathic Pain Market

DelveInsight's Peripheral Neuropathic Pain - Market Insights, Epidemiology and Market Forecast - 2030 report provides a detailed overview of the disease and a depth understanding of historical and forecasted epidemiology.

  •  Chronic Pain Associated with Painful Diabetic Neuropathy Market, Epidemiology, and Market Forecast

Chronic Pain Associated with Painful Diabetic Neuropathy Market research report presents a detailed analysis of the market size, shares, trends, epidemiology, therapies, and pipeline insights

  • Leber's Hereditary Optic Neuropathy (LHON) Market

DelveInsight's Leber's Hereditary Optic Neuropathy (LHON) - Market Insights, Epidemiology and Market Forecast - 2030 report provides a detailed overview of the disease and a depth understanding of historical and forecasted epidemiology.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.  It also proffers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Contact Us:

Shruti Thakur 
info@delveinsight.com  
+1(919)321-6187 
www.delveinsight.com

Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg

Modal title

Also from this source

GPCR-Targeting Therapies Market Poised for Strong Growth During the Forecast Period (2025-2034) Across 7MM Due to the Rising Cancer Diagnoses and Drug Pipeline Expansion | DelveInsight

GPCR-Targeting Therapies Market Poised for Strong Growth During the Forecast Period (2025-2034) Across 7MM Due to the Rising Cancer Diagnoses and Drug Pipeline Expansion | DelveInsight

DelveInsight's GPCR-Targeting Therapies Market Size, Target Population, Competitive Landscape & Market Forecast report includes a comprehensive...

Post-Traumatic Stress Disorder Market Set to Expand Significantly During the Study Period (2020-2034) with Pipeline Innovation and Unmet Needs | DelveInsight

Post-Traumatic Stress Disorder Market Set to Expand Significantly During the Study Period (2020-2034) with Pipeline Innovation and Unmet Needs | DelveInsight

DelveInsight's Post-Traumatic Stress Disorder Market Insights report includes a comprehensive understanding of current treatment practices,...

More Releases From This Source

Explore

Medical Equipment

Medical Equipment

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.